Search Results - "Tata, Prasanthi"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy by Rodriguez, Jonathan, Iniguez, Abdon, Jena, Nilamani, Tata, Prasanthi, Liu, Zhong-Ying, Lander, Arthur D, Lowengrub, John, Van Etten, Richard A

    Published in eLife (28-04-2023)
    “…Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturing myeloid cells driven by the product of the Philadelphia…”
    Get full text
    Journal Article
  2. 2

    The impact of Rhodiola rosea on biomarkers of diabetes, inflammation, and microbiota in a leptin receptor-knockout mouse model by Jafari, Mahtab, Juanson Arabit, Jasmin Grace, Courville, Robert, Kiani, Dara, Chaston, John M., Nguyen, Cindy Duy, Jena, Nilamani, Liu, Zhong-Ying, Tata, Prasanthi, Van Etten, Richard A.

    Published in Scientific reports (22-06-2022)
    “…Type 2 diabetes is the most prevalent endocrine disease in the world, and recently the gut microbiota have become a potential target for its management. Recent…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Optimal experimental design for mathematical models of haematopoiesis by Lomeli, Luis Martinez, Iniguez, Abdon, Tata, Prasanthi, Jena, Nilamani, Liu, Zhong-Ying, Van Etten, Richard, Lander, Arthur D, Shahbaba, Babak, Lowengrub, John S, Minin, Vladimir N

    Published in Journal of the Royal Society interface (01-01-2021)
    “…The haematopoietic system has a highly regulated and complex structure in which cells are organized to successfully create and maintain new blood cells. It is…”
    Get full text
    Journal Article
  6. 6

    Overexpression of Calreticulin Impairs Self-Renewal Capacity of Hematopoietic Stem Cells by Brooks, Stefan, Morse, Sarah, Craver, Brianna, Lai, Hew Yeng, Nguyen, Thanh Kim, Kim, Daniel, Fleischman, Angela G., Tata, Prasanthi, Jena, Nilamani, Liu, Zhong-Ying, Van Etten, Richard A.

    Published in Blood (08-12-2017)
    “…Mutations in JAK2, c-MPL and CALR have all been identified as drivers of MPN pathogenesis. JAK2 and c-MPL are critical for hematopoietic stem cell self-renewal…”
    Get full text
    Journal Article
  7. 7

    The MEK/ERK Inhibitor Trametinib Reduces Fibrosis in a Transduction-Transplantation Model of Mutated Calreticulin by Nguyen, Thanh Kim, Tata, Prasanthi, Brooks, Stefan, Jena, Nilamani, Morse, Sarah J, Liu, Zhong-ying, Lai, Hew Yeng, Rezk, Sherif, Van Etten, Richard A., Fleischman, Angela G

    Published in Blood (02-12-2016)
    “…▪ Insertion or deletion mutations in calreticulin (CALR) are present in the majority of JAK2V617F-negative MPN patients. We utilized a murine retroviral…”
    Get full text
    Journal Article
  8. 8

    High-Throughput Immunoglobulin Heavy Chain Variable Region Repertoire Analysis Of CD27+ B Cell Subsets From Patients With Chronic Gvhd by Tata, Prasanthi V., Vincent, Benjamin G., Kuan, Pei-Fen, Jones, Corbin, Serody, Jonathan, Sarantopoulos, Stefanie

    Published in Blood (15-11-2013)
    “…Patients with chronic graft versus host disease (cGVHD) have persistently altered B cell homeostasis and loss of B cell tolerance, even years after allogeneic…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Evaluation of MUC4 glycoprotein as a potential target for immunoliposomes in the treatment of pancreatic adenocarcinoma by Tata, Prasanthi

    Published 01-01-2008
    “…The purpose of this study is to understand the extent to which MUC4 (mucin) can be used to improve targeted delivery to pancreatic tumors and specifically…”
    Get full text
    Dissertation